A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of Cancer.
| Autor: | Dieras, V, Chevallier, B, Kerbrat, P, Krakowski, I, Roche, H, Misset, JL, Lentz, MA, Azli, N, Murawsky, M, Riva, A, Pouillart, P, Fumoleau, P, Misset, J L, Lentz, M A |
|---|---|
| Zdroj: | British Journal of Cancer; Aug1996, Vol. 74 Issue 4, p650-656, 7p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|